Your browser doesn't support javascript.
loading
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
Svensson, Eric C; Madar, Aviv; Campbell, Catarina D; He, Yunsheng; Sultan, Marc; Healey, Margaret L; Xu, Huilei; D'Aco, Katie; Fernandez, Anita; Wache-Mainier, Clarisse; Libby, Peter; Ridker, Paul M; Beste, Michael T; Basson, Craig T.
Affiliation
  • Svensson EC; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Madar A; Now with Boston Pharmaceuticals, Cambridge, Massachusetts.
  • Campbell CD; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • He Y; Now with Valo Health, Boston, Massachusetts.
  • Sultan M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Healey ML; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Xu H; Now with Vanda Pharmaceuticals, Washington, DC.
  • D'Aco K; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Fernandez A; Now with Roche Pharmaceuticals, Basel, Switzerland.
  • Wache-Mainier C; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Libby P; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Ridker PM; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Beste MT; Now with Diamond Age Data Science, Boston, Massachusetts.
  • Basson CT; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
JAMA Cardiol ; 7(5): 521-528, 2022 05 01.
Article in En | MEDLINE | ID: mdl-35385050

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dioxygenases / Atherosclerosis / Antibodies, Monoclonal, Humanized / Clonal Hematopoiesis Type of study: Clinical_trials Limits: Humans Language: En Journal: JAMA Cardiol Year: 2022 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dioxygenases / Atherosclerosis / Antibodies, Monoclonal, Humanized / Clonal Hematopoiesis Type of study: Clinical_trials Limits: Humans Language: En Journal: JAMA Cardiol Year: 2022 Document type: Article Country of publication: Estados Unidos